lomustine has been researched along with Brain Damage, Chronic in 3 studies
Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Epilepsy was the most important risk factor for disability." | 1.32 | Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap. ( Jereb, B; Macedoni-Luksic, M; Todorovski, L, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nicolin, G | 1 |
| Parkin, P | 1 |
| Mabbott, D | 1 |
| Hargrave, D | 1 |
| Bartels, U | 1 |
| Tabori, U | 1 |
| Rutka, J | 1 |
| Buncic, JR | 1 |
| Bouffet, E | 1 |
| Macedoni-Luksic, M | 1 |
| Jereb, B | 1 |
| Todorovski, L | 1 |
| Sunyach, MP | 1 |
| Pommier, P | 1 |
| Martel Lafay, I | 1 |
| Guyotat, J | 1 |
| Ginestet, G | 1 |
| Jouanneau, E | 1 |
| Jouvet, A | 1 |
| Sindou, M | 1 |
| Bret, P | 1 |
| Carrie, C | 1 |
| Frappaz, D | 1 |
1 review available for lomustine and Brain Damage, Chronic
| Article | Year |
|---|---|
Conformal irradiation for pure and mixed oligodendroglioma: the experience of Centre Leon Berard Lyon.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Damage, Chronic; Brain Injuries | 2003 |
2 other studies available for lomustine and Brain Damage, Chronic
| Article | Year |
|---|---|
Natural history and outcome of optic pathway gliomas in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Damage, Chronic; Carboplatin; Chil | 2009 |
Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Brain Damage, Chronic; B | 2003 |